Alanen, H.-M., Finne-Soveri, H., Noro, A., et al (2006) Use of antipsychotic medications among elderly residents in long-term institutional care: a three-year follow-up. International Journal of Geriatric Psychiatry, 21, 288–295.
Alldred, D. P., Petty, D.R., Bowie, P., et al (2007) Antipsychotic prescribing patterns in care homes and relationship with dementia. Psychiatric Bulletin, 31, 329–332.
Anonymous (2007) Lawyers claim ‘concession’ over prescribing for Alzheimer's. BMJ, 335, 11.
Committee on Safety of Medicines (2004) Atypical Anti-psychotic Drugs and Stroke: Message from Gordon Duff, Chairman, Committee on Safety of Medicines (CEM/CMO/2004/1). Medicines and Healthcare Products Regulatory Agency.
Gill, S. S., Rochon, P. A., Herrmann, N., et al (2005) Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ, 330, 445–450.
Gill, S. S., Bronskill, S. E., Normand, S. L. T., et al (2007) Antipsychotic drug use and mortality in older adults with dementia. Annals of Internal Medicine, 146, 775–786.
Hagen, B., Esther, C. A., Ikuta, R., et al (2005) Antipsychotics drug use in Canadian long-term care facilities: prevalence and patterns following resident relocation. International Psychogeriatrics, 17, 179–193.
Lee, P. E., Gill, S. S., Freedman, M., et al (2004) Atypical antipsychotic drugs in the treatment of behvioural and psychological symptoms of dementia: systematic review. BMJ, 329, 75–79.
National Collaborating Centre for Mental Health (2006) Dementia. Supporting People with Dementia and their Carers in Health and Social Care. NICE (http://www.nice.org.uk/Guidance/CG42).
Rochan, P. A., Stukel, T. A., Bronskill, S. E., et al (2007) Variations in nursing home antipsychotic prescribing rates. Archives of Internal Medicine, 167, 676–683.
Royal College of Psychiatrists (2005) Atypical Antipsychotics and Behavioural and Psychiatric Symptoms of Dementia. Royal College of Psychiatrists (http://www.rcpsych.ac.uk/PDF/BPSD.pdf).
Schneider, L. S., Dagerman, K. S. & Insel, P. (2005) Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294, 1934–1943.
Snowdon, J., Day, S. & Baker, W. (2005) Why and how antipsychotic drugs are used in 40 Sydney nursing homes. International Journal of Geriatric Psychiatry, 20, 1146–1152.
Trifirò, G., Verhamme, K. M. C., Ziere, G., et al (2007) All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepidemiology and Drug Safety, 16, 538–544.
Wang, P. S., Schneeweiss, S., Avorn, J., et al (2005) Risk of death in elderly users of conventional vs. atypical antipsychotic medications. New England Journal of Medicine, 353, 2335–2341.
Working Group for the Faculty of the Psychiatry of Old Age of the Royal College of Psychiatrists, Royal College of General Practitioners, British Geriatrics Society & Alzheimer's Society (2004) Guidance for the management of behavioural and psychiatric symptoms in dementia and the treatment of psychosis in people with history of stroke/TIA. Royal College of Psychiatrists.